Evaluate Your GLP-1 Cost Exposure
We provide a conservative analysis of your pharmacy spend trajectory and assess whether managed tapering is appropriate for your population.
Request a Pilot Analysis
For pilot inquiries, ongoing oversight, or managed program discussions, please contact our team directly.
What to include in your inquiry
- Approximate number of employees/covered lives
- Current GLP-1 medication spend (if known)
- Whether you are an employer, benefits consultant, or PBM
- Preferred timeline for engagement
We respond to qualified inquiries within 1 business day. All pilot analyses are subject to minimum cohort size requirements.